Adjuvant Chemotherapy with Nanoparticle Albumin-Bound Paclitaxel and Carboplatin for Stage IB Non-small Cell Lung Cancer

被引:0
|
作者
Motooka, Y. [1 ]
Matsuishi, K. [2 ]
Maruyama, R. [2 ]
Yoshimoto, K. [3 ]
Sakata, S. [1 ]
Aoki, M. [4 ]
Marutsuka, T. [5 ]
Tanaka, F. [6 ]
Suetsugu, T. [7 ]
Suzuki, M. [1 ]
机构
[1] Kumamoto Univ Hosp, Kumamoto, Japan
[2] Omuta Tenryo Hosp, Omuta, Japan
[3] Minami Kyushu Hosp, Natl Hosp Org, Aira, Japan
[4] Kagoshima Univ, Sch Med, Kagoshima, Japan
[5] Kumamoto City Hosp, Kumamoto, Japan
[6] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[7] Kagoshima Univ, Kagoshima, Japan
关键词
early stage NSCLC; adjuvant chemotherapy; phase II multicenter clinical trial;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP07.02-10
引用
收藏
页码:S528 / S529
页数:2
相关论文
共 50 条
  • [41] Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma
    Takahashi, Akiko
    Noro, Rintaro
    Takano, Natsuki
    Hisakane, Kakeru
    Takahashi, Satoshi
    Fukuizumi, Aya
    Omori, Miwako
    Sugano, Teppei
    Takeuchi, Susumu
    Nakamichi, Shinji
    Miyanaga, Akihiko
    Minegishi, Yuji
    Kubota, Kaoru
    Seike, Masahiro
    Gemma, Akihiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (04)
  • [42] SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
    Komiya, Kazutoshi
    Nakamura, Tomomi
    Nakashima, Chiho
    Takahashi, Koichiro
    Umeguchi, HiItomi
    Watanabe, Naomi
    Sato, Akemi
    Takeda, Yuji
    Kimura, Shinya
    Sueoka-Aragane, Naoko
    ONCOTARGETS AND THERAPY, 2016, 9 : 6663 - 6668
  • [43] Meta-analysis of the efficacy of postoperative adjuvant chemotherapy for stage IB non-small cell lung cancer
    Liu, Siqi
    Wan, Sha
    Feng, Jinghui
    Pang, Yaqi
    Wang, Haiqing
    Zeng, Hui
    Xu, Xinhua
    MEDICINE, 2024, 103 (01) : E36839
  • [44] A Novel Nomogram for Identifying Candidates for Adjuvant Chemotherapy in Patients With Stage IB Non-small Cell Lung Cancer
    Song, Xue
    Xie, Yangyang
    Deng, Haoran
    Yu, Fei
    Wang, Shiqiang
    Lou, Yafang
    CANCER CONTROL, 2023, 30
  • [45] Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion
    Kim, Bo-Guen
    Choi, Juwhan
    Lee, Sun-Kyung
    Choi, Sue In
    Park, Chan Kwon
    Sim, Jae Kyeom
    Lee, Hyun
    Kim, Sang-Heon
    Sohn, Jang Won
    Yoon, Ho Joo
    Lee, Sung Yong
    Park, Dong Won
    JOURNAL OF THORACIC DISEASE, 2024, 16 (02) : 875 - 883
  • [46] Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    Park, Hye Jung
    Park, Heae Surng
    Cha, Yoon Jin
    Lee, Sungsoo
    Jeung, Hei-Cheul
    Cho, Jae Yong
    Kim, Hyung Jung
    Byun, Min Kwang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2279 - 2287
  • [47] Paclitaxel and carboplatin in nonoperable non-small cell lung cancer
    Kosmidis, P
    Mylonakis, N
    Fountzilas, G
    Samantas, E
    Athanasiadis, A
    Skarlos, D
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 16 - 18
  • [48] Dose-dense nab-paclitaxel (nanoparticle albumin-bound paclitaxel) in adjuvant chemotherapy for breast cancer: A feasibility study
    Burstein, H. J.
    Mayer, E. L.
    Peppercorn, J.
    Parker, L. M.
    Hannagan, K.
    Moy, B.
    Younger, J.
    Schapira, L.
    Wulf, G.
    Gelman, R.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer
    Yoshida, Hironori
    Kim, Young Hak
    Ozasa, Hiroaki
    Nagai, Hiroki
    Sakamori, Yuichi
    Nakaoku, Takashi
    Yagi, Yoshitaka
    Tsuji, Takahiro
    Nomizo, Takashi
    Mishima, Michiaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 213 - 215
  • [50] Retrospective analysis of nanoparticle albumin-bound paclitaxel (nabP) administered as a single agent in the treatment of recurrent stage IV (st4) non-small cell lung cancer (NSCLC).
    Saxena, Ashish
    Christos, Paul J.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)